MS Town Hall Meeting in Valdosta, GA on 01/21/2012

In this MS Town Hall Meeting, interactive topics include:

1. Disease modification -- newest research, currently approved medications and complementary and alternative medications (CAM). Emerging therapies:BG12, Lemtrada, Teriflunomide, Ocrelizumab, Daclizumab, Pegylated Interferon Beta-1a....

Factors include: Efficacy vs. Safety vs. Tolerability vs. Convenience (Route of administration vs. frequency).

2. Symptom control -- how to talk to your doctors and prioritize your issues. The use of NeuroFunctional Enhancers (NFEs). This does NOT necessarily mean medications.

3. Rescue treatments -- IV Solumedrol (Methylprednisolone), IM/SC ACTH, IVIG/IGIV, plasmapheresis). Only 2 FDA approved treatments (SOLUMEDROL and H.P. ACTHAR GEL).

Also, side effects of medications and how to deal with them. What to do when your insurance denies your needed medication.







Here are the flip chart notes:







- Dr. Daniel Kantor, MD
Medical Director
Neurologique

info@neurologique.org
www.neurologique.org